---
title: "Mitochondrial Dysfunction in T-Cell Exhaustion and Its Impact on Cancer Immunotherapy"
id: "pubmed-43059381"
canonical_url: "https://medichelpline.com/clinical-feed/pubmed-43059381"
content_type: "clinical_feed_article"
specialty: "Oncology"
source_name: "PubMed / NCBI"
source_url: "https://pubmed.ncbi.nlm.nih.gov/43059381/"
doi: "10.3892/ijo.2026.5959"
published_at: "2026-11-20T12:00:00.000Z"
evidence_level: "Journal Article"
license: "CC-BY-NC-4.0 / Informational Use"
---
# Mitochondrial Dysfunction in T-Cell Exhaustion and Its Impact on Cancer Immunotherapy
## Provenance & Clinical Metadata
- **Canonical URL:** https://medichelpline.com/clinical-feed/pubmed-43059381
- **Specialty:** [Oncology](https://medichelpline.com/clinical-feed/oncology.md)
- **Primary Source:** PubMed / NCBI
- **Source URL:** [Original Journal Publication](https://pubmed.ncbi.nlm.nih.gov/43059381/)
- **DOI:** [10.3892/ijo.2026.5959](https://doi.org/10.3892%2Fijo.2026.5959)
- **Published At:** 2026-11-20T12:00:00.000Z
- **Evidence Rating:** Journal Article
## Executive GIST (TL;DR)
- Mitochondria regulate T‑cell function and are implicated in the dysfunction of tumor‑infiltrating lymphocytes. - T‑cell exhaustion is defined by reduced effector activity and persistent inhibitory receptor expression, limiting antitumor immunity. - The review synthesized mechanistic and translational literature linking mitochondrial dynamics, **mitophagy**, and mitochondrial reactive oxygen species to T‑cell decline in tumors. - Authors organized evidence by intervention class and level of evidence to separate clinically advanced strategies from proof‑of‑concept work. - Four intervention classes are detailed: metabolic reprogramming; enhancement of mitochondrial biogenesis; redox‑directed modulation; intercellular mitochondrial transfer. - Pharmacological and nanoscale mitochondrial delivery platforms are discussed as routes to target mitochondrial dysfunction. - Clinical translation was assessed against ClinicalTrials.gov entries; the most advanced clinical evaluations investigate **metformin** combined with **immune checkpoint inhibitors**. - The review situates mitochondrial dysfunction alongside other established drivers of exhaustion rather than as a sole dominant constraint. - Limitations of the available evidence are stated in the review, and specific research questions required before routine mitochondrial targeting in immunotherapy are identified. - The therapeutic argument presented: mitochondria represent a mechanistically tractable and pharmacologically accessible component of a multifactorial resistance program, offering targetable avenues to augment immunotherapy response.
## Clinical Analysis & Structured Key Points
Clipboard, Search History, and several other advanced features are temporarily unavailable. [ Skip to main page content ](https://pubmed.ncbi.nlm.nih.gov/43059381/#article-details) ### NIH Websites Are Changing * [Get the Latest Updates and FAQs on the transition](https://www.nih.gov/web-modernization) * Per [Executive Order 14434](https://www.whitehouse.gov/presidential-actions/2026/09/inaugurating-the-era-of-super-intelligence/), federal agencies are now using "Super Intelligence" (SI) in place of "Artificial Intelligence" (AI). You may see both terms across NIH content during this transition. ![U.S. flag](https://cdn.ncbi.nlm.nih.gov/coreutils/uswds/img/favicons/favicon-57.png) An official website of the United States government Here's how you know ![Dot gov](https://cdn.ncbi.nlm.nih.gov/coreutils/uswds/img/icon-dot-gov.svg) **The .gov means it’s official.** Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site. ![Https](https://cdn.ncbi.nlm.nih.gov/coreutils/uswds/img/icon-https.svg) **The site is secure.** The **https://** ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely. [ ![NIH NLM Logo](https://cdn.ncbi.nlm.nih.gov/coreutils/nwds/img/logos/AgencyLogo.svg) ](https://www.ncbi.nlm.nih.gov/) [Log in](https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpubmed.ncbi.nlm.nih.gov%2F43059381%2F) Show account info Close #### Account Logged in as: **username** * [Dashboard](https://www.ncbi.nlm.nih.gov/myncbi/) * [Publications](https://www.ncbi.nlm.nih.gov/myncbi/collections/bibliography/) * [Account settings](https://www.ncbi.nlm.nih.gov/account/settings/) * [Log out](https://www.ncbi.nlm.nih.gov/account/signout/?back_url=https%3A//pubmed.ncbi.nlm.nih.gov/43059381/) [Access keys](https://www.ncbi.nlm.nih.gov/guide/browsers/#ncbi_accesskeys) [NCBI Homepage](https://www.ncbi.nlm.nih.gov) [MyNCBI Homepage](https://pubmed.ncbi.nlm.nih.gov/myncbi/) [Main Content](https://pubmed.ncbi.nlm.nih.gov/43059381/#maincontent) [Main Navigation](https://pubmed.ncbi.nlm.nih.gov/43059381/) [ ![pubmed logo](https://cdn.ncbi.nlm.nih.gov/pubmed/a447896c-976f-490b-b86b-2668b65114a8/core/images/pubmed-logo-blue.svg) ](https://pubmed.ncbi.nlm.nih.gov/) [ ](https://pubmed.ncbi.nlm.nih.gov/43059381/ "Show search bar") Search: [](https://pubmed.ncbi.nlm.nih.gov/43059381/ "Clear search input")Search [Advanced](https://pubmed.ncbi.nlm.nih.gov/advanced/) [ Clipboard ](https://pubmed.ncbi.nlm.nih.gov/clipboard/) [ User Guide ](https://pubmed.ncbi.nlm.nih.gov/help/) Save Email Send to * [ Clipboard ](https://pubmed.ncbi.nlm.nih.gov/43059381/) * [My Bibliography](https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpubmed.ncbi.nlm.nih.gov%2F43059381%2F%23open-bibliography-panel) * [Collections](https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpubmed.ncbi.nlm.nih.gov%2F43059381%2F%23open-collections-panel) * [Citation manager](https://pubmed.ncbi.nlm.nih.gov/43059381/) Display options Display options Format Abstract PubMed PMID ## Save citation to file Format: Summary (text) PubMed PMID Abstract (text) CSV Create file Cancel ## Email citation Email address has not been verified. Go to [ My NCBI account settings ](https://account.ncbi.nlm.nih.gov/settings/) to confirm your email and then refresh this page. To: Subject: Body: Format: Summary Summary (text) Abstract Abstract (text) MeSH and other data Send email Cancel ### Add to Collections * Create a new collection * Add to an existing collection Name your collection: Name must be less than 100 characters Choose a collection: Unable to load your collection due to an error [Please try again](https://pubmed.ncbi.nlm.nih.gov/43059381/) Add Cancel ### Add to My Bibliography * My Bibliography Unable to load your delegates due to an error [Please try again](https://pubmed.ncbi.nlm.nih.gov/43059381/) Add Cancel ## Your saved search Name of saved search: Search terms: [Test search terms](https://pubmed.ncbi.nlm.nih.gov/43059381/) Would you like email updates of new search results? Saved Search Alert Radio Buttons * Yes * No Email: ([change](https://www.ncbi.nlm.nih.gov/account/settings/)) Frequency: Monthly Weekly Daily Which day? The first Sunday The first Monday The first Tuesday The first Wednesday The first Thursday The first Friday The first Saturday The first day The first weekday Which day? Sunday Monday Tuesday Wednesday Thursday Friday Saturday Report format: Summary Summary (text) Abstract Abstract (text) PubMed Send at most: 1 item 5 items 10 items 20 items 50 items 100 items 200 items Send even when there aren't any new results Optional text in email: Save Cancel ## Create a file for external citation management software Create file Cancel ## Your RSS Feed Name of RSS Feed: Number of items displayed: 5 10 15 20 50 100 Create RSS Cancel RSS Link Copy ### Actions Cite Collections Add to Collections * Create a new collection * Add to an existing collection Name your collection: Name must be less than 100 characters Choose a collection: Unable to load your collection due to an error [Please try again](https://pubmed.ncbi.nlm.nih.gov/43059381/) Add Cancel Permalink Permalink Copy Display options Display options Format Abstract PubMed PMID ### Experimental Resource Linked Discoveries ### Page navigation * [ Title & authors ](https://pubmed.ncbi.nlm.nih.gov/43059381/#heading) * [ Abstract ](https://pubmed.ncbi.nlm.nih.gov/43059381/#abstract) * [ Publication types ](https://pubmed.ncbi.nlm.nih.gov/43059381/#publication-types) * [ MeSH terms ](https://pubmed.ncbi.nlm.nih.gov/43059381/#mesh-terms) * [ Substances ](https://pubmed.ncbi.nlm.nih.gov/43059381/#substances) Title & authors Abstract Publication types MeSH terms Substances Review Int J Oncol Actions * [ Search in PubMed ](https://pubmed.ncbi.nlm.nih.gov/?term=%22Int+J+Oncol%22%5Bjour%5D&sort=date&sort_order=desc) * [ Search in NLM Catalog ](https://www.ncbi.nlm.nih.gov/nlmcatalog?term=%22Int+J+Oncol%22%5BTitle+Abbreviation%5D) * [ Add to Search ](https://pubmed.ncbi.nlm.nih.gov/43059381/) . 2026 Dec;69(6):146. doi: 10.3892/ijo.2026.5959. Epub 2026 Nov 20. # Mitochondrial dysfunction in T‑cell exhaustion: Its contribution to the efficacy of cancer immunotherapy (Review) [Yanan Shao](https://pubmed.ncbi.nlm.nih.gov/?term=Shao+Y&cauthor_id=43059381)[ 1 ](https://pubmed.ncbi.nlm.nih.gov/43059381/#full-view-affiliation-1 "Shenzhen Hospital of Integrated Traditional Chinese and Western Medicine, Shenzhen, Guangdong 518104, P.R. China."), [Min Gao](https://pubmed.ncbi.nlm.nih.gov/?term=Gao+M&cauthor_id=43059381)[ 2 ](https://pubmed.ncbi.nlm.nih.gov/43059381/#full-view-affiliation-2 "Faculty of Chinese Medicine, Macau University of Science and Technology, Macau, P.R. China."), [Shuqing Mao](https://pubmed.ncbi.nlm.nih.gov/?term=Mao+S&cauthor_id=43059381)[ 3 ](https://pubmed.ncbi.nlm.nih.gov/43059381/#full-view-affiliation-3 "Department of Intensive Care Unit, The Central Hospital of Yongzhou, Yongzhou, Hunan 425006, P.R. China."), [Haibo Li](https://pubmed.ncbi.nlm.nih.gov/?term=Li+H&cauthor_id=43059381)[ 1 ](https://pubmed.ncbi.nlm.nih.gov/43059381/#full-view-affiliation-1 "Shenzhen Hospital of Integrated Traditional Chinese and Western Medicine, Shenzhen, Guangdong 518104, P.R. China."), [Jian Cui](https://pubmed.ncbi.nlm.nih.gov/?term=Cui+J&cauthor_id=43059381)[ 4 ](https://pubmed.ncbi.nlm.nih.gov/43059381/#full-view-affiliation-4 "Institute of Cardiovascular Disease, The First Affiliated Hospital, Hengyang Medical School, University of South China, Hengyang, Hunan 421001, P.R. China.") Affiliations Expand ### Affiliations * 1 Shenzhen Hospital of Integrated Traditional Chinese and Western Medicine, Shenzhen, Guangdong 518104, P.R. China. * 2 Faculty of Chinese Medicine, Macau University of Science and Technology, Macau, P.R. China. * 3 Department of Intensive Care Unit, The Central Hospital of Yongzhou, Yongzhou, Hunan 425006, P.R. China. * 4 Institute of Cardiovascular Disease, The First Affiliated Hospital, Hengyang Medical School, University of South China, Hengyang, Hunan 421001, P.R. China. * PMID: **43059381** * DOI: [ 10.3892/ijo.2026.5959 ](https://doi.org/10.3892/ijo.2026.5959) Item in Clipboard Review # Mitochondrial dysfunction in T‑cell exhaustion: Its contribution to the efficacy of cancer immunotherapy (Review) Yanan Shao et al. Int J Oncol. 2026 Dec. Show details Display options Display options Format Abstract PubMed PMID Int J Oncol Actions * [ Search in PubMed ](https://pubmed.ncbi.nlm.nih.gov/?term=%22Int+J+Oncol%22%5Bjour%5D&sort=date&sort_order=desc) * [ Search in NLM Catalog ](https://www.ncbi.nlm.nih.gov/nlmcatalog?term=%22Int+J+Oncol%22%5BTitle+Abbreviation%5D) * [ Add to Search ](https://pubmed.ncbi.nlm.nih.gov/43059381/) . 2026 Dec;69(6):146. doi: 10.3892/ijo.2026.5959. Epub 2026 Nov 20. ### Authors [Yanan Shao](https://pubmed.ncbi.nlm.nih.gov/?term=Shao+Y&cauthor_id=43059381)[ 1 ](https://pubmed.ncbi.nlm.nih.gov/43059381/#short-view-affiliation-1 "Shenzhen Hospital of Integrated Traditional Chinese and Western Medicine, Shenzhen, Guangdong 518104, P.R. China."), [Min Gao](https://pubmed.ncbi.nlm.nih.gov/?term=Gao+M&cauthor_id=43059381)[ 2 ](https://pubmed.ncbi.nlm.nih.gov/43059381/#short-view-affiliation-2 "Faculty of Chinese Medicine, Macau University of Science and Technology, Macau, P.R. China."), [Shuqing Mao](https://pubmed.ncbi.nlm.nih.gov/?term=Mao+S&cauthor_id=43059381)[ 3 ](https://pubmed.ncbi.nlm.nih.gov/43059381/#short-view-affiliation-3 "Department of Intensive Care Unit, The Central Hospital of Yongzhou, Yongzhou, Hunan 425006, P.R. China."), [Haibo Li](https://pubmed.ncbi.nlm.nih.gov/?term=Li+H&cauthor_id=43059381)[ 1 ](https://pubmed.ncbi.nlm.nih.gov/43059381/#short-view-affiliation-1 "Shenzhen Hospital of Integrated Traditional Chinese and Western Medicine, Shenzhen, Guangdong 518104, P.R. China."), [Jian Cui](https://pubmed.ncbi.nlm.nih.gov/?term=Cui+J&cauthor_id=43059381)[ 4 ](https://pubmed.ncbi.nlm.nih.gov/43059381/#short-view-affiliation-4 "Institute of Cardiovascular Disease, The First Affiliated Hospital, Hengyang Medical School, University of South China, Hengyang, Hunan 421001, P.R. China.") ### Affiliations * 1 Shenzhen Hospital of Integrated Traditional Chinese and Western Medicine, Shenzhen, Guangdong 518104, P.R. China. * 2 Faculty of Chinese Medicine, Macau University of Science and Technology, Macau, P.R. China. * 3 Department of Intensive Care Unit, The Central Hospital of Yongzhou, Yongzhou, Hunan 425006, P.R. China. * 4 Institute of Cardiovascular Disease, The First Affiliated Hospital, Hengyang Medical School, University of South China, Hengyang, Hunan 421001, P.R. China. * PMID: **43059381** * DOI: [ 10.3892/ijo.2026.5959 ](https://doi.org/10.3892/ijo.2026.5959) Item in Clipboard Cite Display options Display options Format Abstract PubMed PMID Linked Discoveries ## Abstract Mitochondria play a pivotal role in the regulation of T‑cell function, particularly in the context of T‑cell exhaustion within the tumor microenvironment. T‑cell exhaustion, characterized by impaired effector functions and the sustained expression of inhibitory receptors, poses a significant barrier to effective antitumor immunity and limits the success of immunotherapies. Emerging evidence indicates that mitochondrial dysfunction is a contributor to the metabolic and functional decline of tumor‑infiltrating lymphocytes. The present review critically synthesizes the available mechanistic and translational literature on mitochondrial dysfunction in T‑cell exhaustion, with particular attention paid to mitochondrial dynamics, mitophagy, and the threshold‑dependent duality of mitochondrial reactive oxygen species. The evidence is organized not by pathway alone, but by intervention class and level of evidence, so that the strategies with demonstrated clinical traction can be distinguished from those that remain at the proof‑of‑concept stage. Of note, four intervention classes are discussed: Metabolic reprogramming, enhancement of mitochondrial biogenesis, redox‑directed modulation and intercellular mitochondrial transfer, together with mitochondria‑directed pharmacological and nanoscale delivery platforms. Clinical translation is assessed against trials registered on ClinicalTrials.gov, of which the most advanced evaluate metformin in combination with immune checkpoint inhibitors. Mitochondrial dysfunction is also placed in the context of other established drivers of exhaustion, the limitations of the available evidence are stated, and the specific questions that need to be answered before mitochondrial targeting can be incorporated into immunotherapy regimens are also stated. Rather than claiming that mitochondrial dysfunction is a single dominant constraint, it is argued herein that its therapeutic value lies in being a mechanistically tractable and pharmacologically accessible component of a multifactorial resistance program. **Keywords:** T‑cell exhaustion; mitochondria; mitochondrial dynamics; tumor immunotherapy. [PubMed Disclaimer](https://pubmed.ncbi.nlm.nih.gov/disclaimer/) ## Publication types * Review Actions * [ Search in PubMed ](https://pubmed.ncbi.nlm.nih.gov/?term=%22Review%22%5Bpt%5D&sort=date&sort_order=desc) * [ Search in MeSH ](https://www.ncbi.nlm.nih.gov/mesh?term=Review) * [ Add to Search ](https://pubmed.ncbi.nlm.nih.gov/43059381/) ## MeSH terms * Animals Actions * [ Search in PubMed ](https://pubmed.ncbi.nlm.nih.gov/?term=%22Animals%22%5BMeSH%5D&sort=date&sort_order=desc) * [ Search in MeSH ](https://www.ncbi.nlm.nih.gov/mesh?term=Animals) * [ Add to Search ](https://pubmed.ncbi.nlm.nih.gov/43059381/) * Humans Actions * [ Search in PubMed ](https://pubmed.ncbi.nlm.nih.gov/?term=%22Humans%22%5BMeSH%5D&sort=date&sort_order=desc) * [ Search in MeSH ](https://www.ncbi.nlm.nih.gov/mesh?term=Humans) * [ Add to Search ](https://pubmed.ncbi.nlm.nih.gov/43059381/) * Immune Checkpoint Inhibitors / pharmacology Actions * [ Search in PubMed ](https://pubmed.ncbi.nlm.nih.gov/?term=%22Immune+Checkpoint+Inhibitors%2Fpharmacology%22%5BMeSH%5D&sort=date&sort_order=desc) * [ Search in MeSH ](https://www.ncbi.nlm.nih.gov/mesh?term=Immune+Checkpoint+Inhibitors) * [ Add to Search ](https://pubmed.ncbi.nlm.nih.gov/43059381/) * Immune Checkpoint Inhibitors / therapeutic use Actions * [ Search in PubMed ](https://pubmed.ncbi.nlm.nih.gov/?term=%22Immune+Checkpoint+Inhibitors%2Ftherapeutic+use%22%5BMeSH%5D&sort=date&sort_order=desc) * [ Search in MeSH ](https://www.ncbi.nlm.nih.gov/mesh?term=Immune+Checkpoint+Inhibitors) * [ Add to Search ](https://pubmed.ncbi.nlm.nih.gov/43059381/) * Immunotherapy* / methods Actions * [ Search in PubMed ](https://pubmed.ncbi.nlm.nih.gov/?term=%22Immunotherapy%2Fmethods%22%5BMAJR%5D&sort=date&sort_order=desc) * [ Search in MeSH ](https://www.ncbi.nlm.nih.gov/mesh?term=Immunotherapy) * [ Add to Search ](https://pubmed.ncbi.nlm.nih.gov/43059381/) * Lymphocytes, Tumor-Infiltrating / drug effects Actions * [ Search in PubMed ](https://pubmed.ncbi.nlm.nih.gov/?term=%22Lymphocytes%2C+Tumor-Infiltrating%2Fdrug+effects%22%5BMeSH%5D&sort=date&sort_order=desc) * [ Search in MeSH ](https://www.ncbi.nlm.nih.gov/mesh?term=Lymphocytes%2C+Tumor-Infiltrating) * [ Add to Search ](https://pubmed.ncbi.nlm.nih.gov/43059381/) * Lymphocytes, Tumor-Infiltrating / immunology Actions * [ Search in PubMed ](https://pubmed.ncbi.nlm.nih.gov/?term=%22Lymphocytes%2C+Tumor-Infiltrating%2Fimmunology%22%5BMeSH%5D&sort=date&sort_order=desc) * [ Search in MeSH ](https://www.ncbi.nlm.nih.gov/mesh?term=Lymphocytes%2C+Tumor-Infiltrating) * [ Add to Search ](https://pubmed.ncbi.nlm.nih.gov/43059381/) * Metabolic Reprogramming Actions * [ Search in PubMed ](https://pubmed.ncbi.nlm.nih.gov/?term=%22Metabolic+Reprogramming%22%5BMeSH%5D&sort=date&sort_order=desc) * [ Search in MeSH ](https://www.ncbi.nlm.nih.gov/mesh?term=Metabolic+Reprogramming) * [ Add to Search ](https://pubmed.ncbi.nlm.nih.gov/43059381/) * Mitochondria* / drug effects Actions * [ Search in PubMed ](https://pubmed.ncbi.nlm.nih.gov/?term=%22Mitochondria%2Fdrug+effects%22%5BMAJR%5D&sort=date&sort_order=desc) * [ Search in MeSH ](https://www.ncbi.nlm.nih.gov/mesh?term=Mitochondria) * [ Add to Search ](https://pubmed.ncbi.nlm.nih.gov/43059381/) * Mitochondria* / immunology Actions * [ Search in PubMed ](https://pubmed.ncbi.nlm.nih.gov/?term=%22Mitochondria%2Fimmunology%22%5BMAJR%5D&sort=date&sort_order=desc) * [ Search in MeSH ](https://www.ncbi.nlm.nih.gov/mesh?term=Mitochondria) * [ Add to Search ](https://pubmed.ncbi.nlm.nih.gov/43059381/) * Mitochondria* / metabolism Actions * [ Search in PubMed ](https://pubmed.ncbi.nlm.nih.gov/?term=%22Mitochondria%2Fmetabolism%22%5BMAJR%5D&sort=date&sort_order=desc) * [ Search in MeSH ](https://www.ncbi.nlm.nih.gov/mesh?term=Mitochondria) * [ Add to Search ](https://pubmed.ncbi.nlm.nih.gov/43059381/) * Mitochondria* / pathology Actions * [ Search in PubMed ](https://pubmed.ncbi.nlm.nih.gov/?term=%22Mitochondria%2Fpathology%22%5BMAJR%5D&sort=date&sort_order=desc) * [ Search in MeSH ](https://www.ncbi.nlm.nih.gov/mesh?term=Mitochondria) * [ Add to Search ](https://pubmed.ncbi.nlm.nih.gov/43059381/) * Mitochondrial Dynamics / drug effects Actions * [ Search in PubMed ](https://pubmed.ncbi.nlm.nih.gov/?term=%22Mitochondrial+Dynamics%2Fdrug+effects%22%5BMeSH%5D&sort=date&sort_order=desc) * [ Search in MeSH ](https://www.ncbi.nlm.nih.gov/mesh?term=Mitochondrial+Dynamics) * [ Add to Search ](https://pubmed.ncbi.nlm.nih.gov/43059381/) * Mitochondrial Dynamics / immunology Actions * [ Search in PubMed ](https://pubmed.ncbi.nlm.nih.gov/?term=%22Mitochondrial+Dynamics%2Fimmunology%22%5BMeSH%5D&sort=date&sort_order=desc) * [ Search in MeSH ](https://www.ncbi.nlm.nih.gov/mesh?term=Mitochondrial+Dynamics) * [ Add to Search ](https://pubmed.ncbi.nlm.nih.gov/43059381/) * Mitophagy / drug effects Actions * [ Search in PubMed ](https://pubmed.ncbi.nlm.nih.gov/?term=%22Mitophagy%2Fdrug+effects%22%5BMeSH%5D&sort=date&sort_order=desc) * [ Search in MeSH ](https://www.ncbi.nlm.nih.gov/mesh?term=Mitophagy) * [ Add to Search ](https://pubmed.ncbi.nlm.nih.gov/43059381/) * Mitophagy / immunology Actions * [ Search in PubMed ](https://pubmed.ncbi.nlm.nih.gov/?term=%22Mitophagy%2Fimmunology%22%5BMeSH%5D&sort=date&sort_order=desc) * [ Search in MeSH ](https://www.ncbi.nlm.nih.gov/mesh?term=Mitophagy) * [ Add to Search ](https://pubmed.ncbi.nlm.nih.gov/43059381/) * Neoplasms* / drug therapy Actions * [ Search in PubMed ](https://pubmed.ncbi.nlm.nih.gov/?term=%22Neoplasms%2Fdrug+therapy%22%5BMAJR%5D&sort=date&sort_order=desc) * [ Search in MeSH ](https://www.ncbi.nlm.nih.gov/mesh?term=Neoplasms) * [ Add to Search ](https://pubmed.ncbi.nlm.nih.gov/43059381/) * Neoplasms* / immunology Actions * [ Search in PubMed ](https://pubmed.ncbi.nlm.nih.gov/?term=%22Neoplasms%2Fimmunology%22%5BMAJR%5D&sort=date&sort_order=desc) * [ Search in MeSH ](https://www.ncbi.nlm.nih.gov/mesh?term=Neoplasms) * [ Add to Search ](https://pubmed.ncbi.nlm.nih.gov/43059381/) * Neoplasms* / pathology Actions * [ Search in PubMed ](https://pubmed.ncbi.nlm.nih.gov/?term=%22Neoplasms%2Fpathology%22%5BMAJR%5D&sort=date&sort_order=desc) * [ Search in MeSH ](https://www.ncbi.nlm.nih.gov/mesh?term=Neoplasms) * [ Add to Search ](https://pubmed.ncbi.nlm.nih.gov/43059381/) * Neoplasms* / therapy Acti
## Related Clinical Research

- [Metformin alters HMGA1a and RBM3 in breast cancer cells; ESR1 splicing effect varies with density](https://medichelpline.com/clinical-feed/biorxiv-6-metformin-lowers-hmga1a-and-rbm3-protein-in-breast-cancer-cells-and-its-effect.md)
- [Metformin use and incident breast cancer risk: time-bias–aware meta-analysis and limits for imegli](https://medichelpline.com/clinical-feed/medrxiv-8-metformin-use-and-the-risk-of-incident-breast-cancer-a-systematic-review-and.md)
- [Metabolic reprogramming in the immune microenvironment of Ewing sarcoma — article page summary](https://medichelpline.com/clinical-feed/frontiers-in-immunology-8-metabolic-reprogramming-in-the-immune-microenvironment-of-ewing-sarcoma-from.md)
- [YTHDF2 promotes cutaneous melanoma progression via m6A-dependent HMOX1 regulation of ferroptosis](https://medichelpline.com/clinical-feed/pubmed-42848283.md) (DOI: 10.1007/s12032-026-03427-y)
- [Gum acacia–gelatin nanohydrogel co-delivering metformin and doxorubicin inhibits TNT-driven breast](https://medichelpline.com/clinical-feed/pubmed-42605874.md) (DOI: 10.1039/d6bm00697c)

## Navigation
- [← Back to Oncology Feed](https://medichelpline.com/clinical-feed/oncology.md)
- [← All Clinical Specialties](https://medichelpline.com/clinical-feed.md)
## Medical & Regulatory Disclaimer

> [!CAUTION]
> MedicHelpline content is structured for research, educational, and professional discovery purposes. It does not constitute individual medical advice, clinical diagnosis, or treatment recommendations.
> Always verify dosing, contraindications, and regulatory alerts against official product labeling and primary regulatory sources before clinical decision-making.